India’s pharmaceutical industry, valued at US$ 55 billion in FY 2023-24, is rapidly emerging as a global healthcare powerhouse. With projections to reach US$ 130 billion by 2030 and an aspirational US$ 450 billion by 2047, the sector is set to nearly double its global market share to 5%. Already...
Dr Rashmi Banga, Senior Economic Affairs Officer, UNCTAD, states that to move towards global vaccine equity, it is important for the governments to declare vaccines as a public good and not allow pharma industry to put profits before people. For this, waiving off the patents for vaccines and related medical...
Sanjay Singh, Partner – Deal Advisory, Head of Lifesciences, KPMG in India, identifies new generics opportunities, established manufacturing ecosystem, growing penetration of health insurance and talent pool as some of the key growth drivers for the Indian pharmaceutical industry over the next decade. IBT: The government is planning to come...
India Business & Trade is a thought leadership initiative of the Trade Promotion Council of India, a premier trade promotion body recognised by the Department of Commerce, Government of India.
India Business & Trade
M-62, Saket, New Delhi-110064, India
Stay ahead in the dynamic world of trade and commerce with India Business & Trade’s weekly newsletter.
Copyright © 2026 India Business & Trade. All Rights Reserved
